379 related articles for article (PubMed ID: 28127506)
61. Taxane and epothilone-induced peripheral neurotoxicity: From pathogenesis to treatment.
Tamburin S; Park SB; Alberti P; Demichelis C; Schenone A; Argyriou AA
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2():S40-S51. PubMed ID: 31647157
[TBL] [Abstract][Full Text] [Related]
62. Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer.
Griffith KA; Zhu S; Johantgen M; Kessler MD; Renn C; Beutler AS; Kanwar R; Ambulos N; Cavaletti G; Bruna J; Briani C; Argyriou AA; Kalofonos HP; Yerges-Armstrong LM; Dorsey SG
J Pain Symptom Manage; 2017 Nov; 54(5):701-706.e1. PubMed ID: 28743660
[TBL] [Abstract][Full Text] [Related]
63. [Chemotherapy-induced peripheral neuropathy: Symptomatology and epidemiology].
Kerckhove N; Collin A; Condé S; Chaleteix C; Pezet D; Balayssac D; Guastella V
Bull Cancer; 2018 Nov; 105(11):1020-1032. PubMed ID: 30244980
[TBL] [Abstract][Full Text] [Related]
64. Comorbidities and Risk of Chemotherapy-Induced Peripheral Neuropathy Among Participants 65 Years or Older in Southwest Oncology Group Clinical Trials.
Hershman DL; Till C; Wright JD; Awad D; Ramsey SD; Barlow WE; Minasian LM; Unger J
J Clin Oncol; 2016 Sep; 34(25):3014-22. PubMed ID: 27325863
[TBL] [Abstract][Full Text] [Related]
65. Cancer and Peripheral Nerve Disease.
Sarezky J; Sachs G; Elinzano H; Stavros K
Clin Geriatr Med; 2021 May; 37(2):289-300. PubMed ID: 33858611
[TBL] [Abstract][Full Text] [Related]
66. Techniques for the neurological examination of taxane-induced neuropathy.
Ohsumi S; Sunada Y
Breast Cancer; 2004; 11(1):86-91. PubMed ID: 14718799
[TBL] [Abstract][Full Text] [Related]
67. Chemotherapy-induced peripheral neuropathy: a review and implications for oncology nursing practice.
Wickham R
Clin J Oncol Nurs; 2007 Jun; 11(3):361-76. PubMed ID: 17623621
[TBL] [Abstract][Full Text] [Related]
68. [Mechanisms of platinum-induced peripheral neuropathy in cancer patients].
Chubykina SV; Tatarinova MY; Avakyan GG
Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(7):19-24. PubMed ID: 37490661
[TBL] [Abstract][Full Text] [Related]
69. Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale.
Mendoza TR; Wang XS; Williams LA; Shi Q; Vichaya EG; Dougherty PM; Thomas SK; Yucel E; Bastida CC; Woodruff JF; Cleeland CS
J Pain; 2015 Oct; 16(10):1032-43. PubMed ID: 26210041
[TBL] [Abstract][Full Text] [Related]
70. Electronic versus paper-pencil methods for assessing chemotherapy-induced peripheral neuropathy.
Knoerl R; Gray E; Stricker C; Mitchell SA; Kippe K; Smith G; Dudley WN; Lavoie Smith EM
Support Care Cancer; 2017 Nov; 25(11):3437-3446. PubMed ID: 28577231
[TBL] [Abstract][Full Text] [Related]
71. Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy.
Bruna J; Alberti P; Calls-Cobos A; Caillaud M; Damaj MI; Navarro X
Exp Neurol; 2020 Mar; 325():113154. PubMed ID: 31837318
[TBL] [Abstract][Full Text] [Related]
72. Chemotherapy-induced peripheral neuropathy.
Fehrenbacher JC
Prog Mol Biol Transl Sci; 2015; 131():471-508. PubMed ID: 25744683
[TBL] [Abstract][Full Text] [Related]
73. Chemotherapy-induced peripheral neurotoxicity: a critical analysis.
Park SB; Goldstein D; Krishnan AV; Lin CS; Friedlander ML; Cassidy J; Koltzenburg M; Kiernan MC
CA Cancer J Clin; 2013; 63(6):419-37. PubMed ID: 24590861
[TBL] [Abstract][Full Text] [Related]
74. [Chemotherapy induced peripheral neuropathy].
Kolak A; Starosławska E; Kubiatowski T; Kieszko D; Cisek P; Patyra KI; Surdyka D; Mocarska A; Burdan F
Pol Merkur Lekarski; 2013 Nov; 35(209):292-6. PubMed ID: 24575651
[TBL] [Abstract][Full Text] [Related]
75. Toxic neuropathy.
Umapathi T; Chaudhry V
Curr Opin Neurol; 2005 Oct; 18(5):574-80. PubMed ID: 16155443
[TBL] [Abstract][Full Text] [Related]
76. Neuronal drug transporters in platinum drugs-induced peripheral neurotoxicity.
Cavaletti G; Ceresa C; Nicolini G; Marmiroli P
Anticancer Res; 2014 Jan; 34(1):483-6. PubMed ID: 24403505
[TBL] [Abstract][Full Text] [Related]
77. Taxane-induced peripheral neuropathy: differences in patient report and objective assessment.
Timmins HC; Li T; Kiernan MC; Baron-Hay S; Marx G; Boyle F; Goldstein D; Park SB
Support Care Cancer; 2020 Sep; 28(9):4459-4466. PubMed ID: 31925531
[TBL] [Abstract][Full Text] [Related]
78. Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review.
Schloss J; Colosimo M; Vitetta L
Crit Rev Food Sci Nutr; 2017 Apr; 57(6):1107-1118. PubMed ID: 25849070
[TBL] [Abstract][Full Text] [Related]
79. Chemotherapy-induced peripheral neurotoxicity.
Cavaletti G; Marmiroli P
Expert Opin Drug Saf; 2004 Nov; 3(6):535-46. PubMed ID: 15500413
[TBL] [Abstract][Full Text] [Related]
80. Peripheral neurotoxic disorders.
Bromberg MB
Neurol Clin; 2000 Aug; 18(3):681-94. PubMed ID: 10873238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
